DelveInsight’s ‘Needle Free Injections -Market Insights, Competitive Landscape and Market Forecast - 2025’ report delivers an in-depth understanding of Needle Free Injections and the historical and forecasted Needle Free Injections market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
The Needle Free Injections market report provides an overview of Needle Free Injections , reasons to get Needle Free Injections as well as its advantages and limitations. Additionally, the report provides insight on the Needle Free Injections market share of the individual Needle Free Injections devices, current and forecasted Needle Free Injections market size from 2017 to 2025 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
Needle-free injection devices are used for penetrating the skin without a traditional needle to deliver liquid formulations, medicines and vaccines to patients. Growing prevalence of chronic disease, fastest growing of communicable disease due to needle stick incidents, increasing demand for biosimilars and vaccination, benefits of drug delivery technologies, increasing demand for self-injection systems, are major factors driving the growth of this market. Needle-free injection systems are used without piercing the skin with a conventional needle to administer liquid formulations, drugs and vaccines to patients. In recent years, demand for these systems has increased significantly as they improve immune responses to vaccines, eliminate needle risks and reduce healthcare costs. However, market growth is impeded by the lack of qualified professionals and the limited use of needle-free injection systems for intravenous administration. The demand for needle-free insulin delivery devices increases the prevalence of diabetes. The global needle free injection systems market is boosted by faster insulin delivery, pain management, technological advancement and self-medication.
Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
Needle Free Injections - Competitive Analysis
This segment of the report provides a brief competitive analysis of Needle Free Injections , to help understand the competition in the market. It gives a comparative understanding of the products based on types of wounds.
Needle Free Injections : Market Analysis
This segment illustrates the market of Needle Free Injections across 7MM and how the market is expected to rise in the study period (2017 to 2025), at a significant CAGR.
To keep up with the market trends, we take KOLs and SME’s opinion working in Needle Free Injections domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Needle Free Injections market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.
Needle Free Injections Report Key Strengths
Needle Free Injections Report Assessment
Market Insights:
1. Key Insights
2. Executive Summary of Needle Free Injections
3. Needle Free Injections : Background and Overview
3.1. Introduction
4. Company Profiles
4.1. Company A
4.1.1. Company Overview
4.1.2 Product Portfolio
4.1.2.1 Product description
4.1.2.2 Regulatory Milestones
4.1.2.3 Research and Development
4.1.2.4 Product Development Activities
4.2. Company B
4.2.1.Company Overview
4.2.2 Product Portfolio
4.2.2.1 Product description
4.2.2.2 Regulatory Milestones
4.2.2.3 Research and Development
4.2.2.4 Product Development Activities
Products detail in the report…
5 Needle Free Injections : Competitive Analysis
6. Needle Free Injections Devices: Market Analysis
6.1. Needle Free Injections : Market Analysis in the 7MM (2017–2025)
6.1.1. Needle Free Injections : Market Analysis in the 7MM by type (2017–2025)
6.1.2. Needle Free Injections : Market Analysis in the 7MM by application (2017–2025)
6.1.3. Needle Free Injections : Market Analysis in the 7MM by end user (2017–2025)
6.2. Needle Free Injections : United States Market Analysis (2017–2025)
6.2.1. Needle Free Injections : Market Analysis in the US by type (2017-2025)
6.2.2. Needle Free Injections : Market Analysis in the US by application (2017-2025)
6.2.3. Needle Free Injections : Market Analysis in the US by end user (2017-2025)
6.3. Needle Free Injections : Germany Market Analysis (2017–2025)
6.3.1. Needle Free Injections : Market Analysis in Germany by type (2017-2025)
6.3.2. Needle Free Injections : Market Analysis in Germany by application (2017-2025)
6.3.3. Needle Free Injections : Market Analysis in Germany by end user (2017-2025)
6.4. Needle Free Injections : France Market Analysis (2017–2025)
6.3.1. Needle Free Injections : Market Analysis in France by type (2017-2025)
6.3.2. Needle Free Injections : Market Analysis in France by application (2017-2025)
6.3.3. Needle Free Injections : Market Analysis in France by end user (2017-2025)
6.5. Needle Free Injections : Italy Market Analysis (2017–2025)
6.5.1. Needle Free Injections : Market Analysis in Italy by type (2017-2025)
6.5.2. Needle Free Injections : Market Analysis in Italy by application (2017-2025)
6.5.3. Needle Free Injections : Market Analysis in Italy by end user (2017-2025)
6.6. Needle Free Injections : Spain Market Analysis (2017–2025)
6.6.1. Needle Free Injections : Market Analysis in Spain by type (2017-2025)
6.6.2. Needle Free Injections : Market Analysis in Spain by application (2017-2025)
6.6.3. Needle Free Injections : Market Analysis in Spain by end user (2017-2025)
6.7. Needle Free Injections : United Kingdom Market Analysis (2017–2025)
6.7.1. Needle Free Injections : Market Analysis in the UK by type (2017-2025)
6.7.2. Needle Free Injections : Market Analysis in the UK by application (2017-2025)
6.7.3. Needle Free Injections : Market Analysis in the UK by end user (2017-2025)
6.8. Needle Free Injections : Japan Market Analysis (2017–2025)
6.8.1. Needle Free Injections : Market Analysis in Japan by type (2017-2025)
6.8.2. Needle Free Injections : Market Analysis in Japan by application (2017-2025)
6.8.3. Needle Free Injections : Market Analysis in Japan by end user (2017-2025)
7. Market Drivers
8. Market Barriers
9. Industry Trends
10. KOL’s Views
11. Analyst Views
12. PEST Analysis
13. Appendix
13.1. Bibliography
13.2. Report Methodology
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
List of Table
Table 1: Competitive Analysis
Table 2: Needle Free Injections : Market Analysis in the 7MM (2017–2025)
Table 3: Needle Free Injections : Market Analysis in the 7MM by type (2017–2025)
Table 4: Needle Free Injections : Market Analysis in the 7MM by application (2017–2025)
Table 5: Needle Free Injections : Market Analysis in the 7MM by end user (2017–2025)
Table 6: Needle Free Injections : United States Market Analysis (2017–2025)
Table 7: Needle Free Injections : Market Analysis in the US by type (2017-2025)
Table 8: Needle Free Injections : Market Analysis in the US by application (2017-2025)
Table 9: Needle Free Injections : Market Analysis in the US by end user (2017-2025)
Table 10: Needle Free Injections : Germany Market Analysis (2017–2025)
Table 11: Needle Free Injections : Market Analysis in Germany by type (2017-2025)
Table 12: Needle Free Injections : Market Analysis in Germany by application (2017-2025)
Table 13: Needle Free Injections : Market Analysis in Germany by end user (2017-2025)
Table 14: Needle Free Injections : France Market Analysis (2017–2025)
Table 15: Needle Free Injections : Market Analysis in France by type (2017-2025)
Table 16: Needle Free Injections : Market Analysis in France by application (2017-2025)
Table 17: Needle Free Injections : Market Analysis in France by end user (2017-2025)
Table 18: Needle Free Injections : Italy Market Analysis (2017–2025)
Table 19: Needle Free Injections : Market Analysis in Italy by type (2017-2025)
Table 20: Needle Free Injections : Market Analysis in Italy by application (2017-2025)
Table 21: Needle Free Injections : Market Analysis in Italy by end user (2017-2025)
Table 22: Needle Free Injections : Spain Market Analysis (2017–2025)
Table 23: Needle Free Injections : Market Analysis in Spain by type (2017-2025)
Table 24: Needle Free Injections : Market Analysis in Spain by application (2017-2025)
Table 25: Needle Free Injections : Market Analysis in Spain by end user (2017-2025)
Table 26: Needle Free Injections : United Kingdom Market Analysis (2017–2025)
Table 27: Needle Free Injections : Market Analysis in the UK by type (2017-2025)
Table 28: Needle Free Injections : Market Analysis in the UK by application (2017-2025)
Table 29: Needle Free Injections : Market Analysis in the UK by end user (2017-2025)
Table 30: Needle Free Injections : Japan Market Analysis (2017–2025)
Table 31: Needle Free Injections : Market Analysis in Japan by type (2017-2025)
Table 32: Needle Free Injections : Market Analysis in Japan by application (2017-2025)
Table 33: Needle Free Injections : Market Analysis in Japan by end user (2017-2025)
List of Figures
Figure 1: Competitive Analysis
Figure 2: Needle Free Injections : Market Analysis in the 7MM (2017–2025)
Figure 3: Needle Free Injections : Market Analysis in the 7MM by type (2017–2025)
Figure 4: Needle Free Injections : Market Analysis in the 7MM by application (2017–2025)
Figure 5: Needle Free Injections : Market Analysis in the 7MM by end user (2017–2025)
Figure 6: Needle Free Injections : United States Market Analysis (2017–2025)
Figure 7: Needle Free Injections : Market Analysis in the US by type (2017-2025)
Figure 8: Needle Free Injections : Market Analysis in the US by application (2017-2025)
Figure 9: Needle Free Injections : Market Analysis in the US by end user (2017-2025)
Figure 10: Needle Free Injections : Germany Market Analysis (2017–2025)
Figure 11: Needle Free Injections : Market Analysis in Germany by type (2017-2025)
Figure 12: Needle Free Injections : Market Analysis in Germany by application (2017-2025)
Figure 13: Needle Free Injections : Market Analysis in Germany by end user (2017-2025)
Figure 14: Needle Free Injections : France Market Analysis (2017–2025)
Figure 15: Needle Free Injections : Market Analysis in France by type (2017-2025)
Figure 16: Needle Free Injections : Market Analysis in France by application (2017-2025)
Figure 17: Needle Free Injections : Market Analysis in France by end user (2017-2025)
Figure 18: Needle Free Injections : Italy Market Analysis (2017–2025)
Figure 19: Needle Free Injections : Market Analysis in Italy by type (2017-2025)
Figure 20: Needle Free Injections : Market Analysis in Italy by application (2017-2025)
Figure 21: Needle Free Injections : Market Analysis in Italy by end user (2017-2025)
Figure 22: Needle Free Injections : Spain Market Analysis (2017–2025)
Figure 23: Needle Free Injections : Market Analysis in Spain by type (2017-2025)
Figure 24: Needle Free Injections : Market Analysis in Spain by application (2017-2025)
Figure 25: Needle Free Injections : Market Analysis in Spain by end user (2017-2025)
Figure 26: Needle Free Injections : United Kingdom Market Analysis (2017–2025)
Figure 27: Needle Free Injections : Market Analysis in the UK by type (2017-2025)
Figure 28: Needle Free Injections : Market Analysis in the UK by application (2017-2025)
Figure 29: Needle Free Injections : Market Analysis in the UK by end user (2017-2025)
Figure 30: Needle Free Injections : Japan Market Analysis (2017–2025)
Figure 31: Needle Free Injections : Market Analysis in Japan by type (2017-2025)
Figure 32: Needle Free Injections : Market Analysis in Japan by application (2017-2025)
Figure 33: Needle Free Injections : Market Analysis in Japan by end user (2017-2025)
Figure 34: Market Drivers
Figure 35: Market Barriers
Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
